Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Blood|June 28, 2019
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group studyAnne Quinquenel, Luc-Matthieu Fornecker, Rémi Letestu, et al.
Blood Advances|October 25, 2019
Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistanceElodie Pramil, Linda Herbi Bastian, Thomas Denèfle, et al.
Medicine|December 16, 2014
Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 casesTomek Kofman, Shao-Yu Zhang, Christiane Copie-Bergman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelinesDamien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Blood|December 4, 2012
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow TransplantationDamien Roos-Weil, Sascha Dietrich, Ariane Boumendil, et al.
Neuroradiology|September 5, 2025
Long-term outcome following vertebroplasty or bone cementoplasty in multiple myeloma patientsSamer Soliman, Laurent Garderet, Kevin Premat, et al.
Seminars in Hematology|May 17, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's MacroglobulinemiaEric Durot, Jithma P Abeykoon, Damien Roos-Weil, et al.
Blood|October 17, 2020
High frequency of clonal hematopoiesis in Erdheim-Chester diseaseFleur Cohen Aubart, Damien Roos-Weil, Marine Armand, et al.
Leukemia|December 9, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic LeukemiaLéa Dehgane, Eliane Mallet, Constance Brasseur, et al.
Blood|September 22, 2020
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapiesMarie Le Cann, Françoise Bouhour, Karine Viala, et al.
Pageof 10